https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=39

Biomedical Research Centre news

Occulome genetic test

​New genetic test leads to faster, more accurate diagnosis of childhood eye disorders

11 Dec 2017, 11:21 a.m.

A new test to help diagnose and predict a range of serious childhood eye conditions has been developed by researchers at Great Ormond Street Hospital (GOSH) and the UCL Great Ormond Street Institute of Child Health (ICH).

Read more

A woman at work in a lab, looking into a microscope.

Low myostatin levels linked to lack of success of anti-myostatin drugs for muscle-wasting conditions

30 Nov 2017, 2:04 p.m.

Levels of myostatin, a protein that prevents muscle growth, could influence how well the body responds to anti-myostatin treatments for muscle-wasting conditions such as Duchenne Muscular Dystrophy (DMD). This breakthrough could help predict which patient

Read more

Researcher Elisa Cuevas in the iPSC facility at GOSH/ICH

Boost for stem cell research at GOSH

21 Nov 2017, 11:30 a.m.

A state-of-the-art stem cell research facility is now open at Great Ormond Street Hospital (GOSH), increasing our capacity for cutting edge research into regenerative medicine.

Read more

Sterile GOSgene laboratory

Advances in the treatment of the severe immune disorder Wiskott-Aldrich syndrome

20 Nov 2017, 2:29 p.m.

Researchers at Great Ormond Street Hospital (GOSH) have made an important breakthrough in understanding how the immune system becomes disrupted in Wiskott-Aldrich syndrome (WAS), a genetic disorder where the patient’s immune cells begin attacking their ow

Read more

​Drug for Duchenne Muscular Dystrophy shows promise in clinical trial

21 Aug 2017, 12:02 p.m.

An international clinical trial has found that the drug ataluren can improve mobility for children with a severe form of Duchenne muscular dystrophy (DMD).

Read more

See more
loading

Filter by:

Category